Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data

Publication date: Available online 1 October 2020Source: CytotherapyAuthor(s): Andreas Kerstan, Elke Niebergall-Roth, Jasmina Esterlechner, Hannes M. Schröder, Martin Gasser, Ana M. Waaga-Gasser, Matthias Goebeler, Katrin Rak, Philipp Schrüfer, Sabrina Endres, Petra Hagenbusch, Korinna Kraft, Kathrin Dieter, Seda Ballikaya, Nicole Stemler, Samar Sadeghi, Nils Tappenbeck, George F. Murphy, Dennis P. Orgill, Natasha Y. Frank

Source: Cytotherapy - October 2, 2020 Category: Cytology Source Type: research